Aakaar Medical Technologies IPO vs Turtle Infratrade IPO

Comparison between Aakaar Medical Technologies IPO and Turtle Infratrade IPO.

IPO Details

Aakaar Medical Technologies IPO is a SME Fixed Price IPO proposed to list at NSE SME while Turtle Infratrade IPO is a SME Fixed Price proposed to list at BSE SME.

Issue Size and Price

The total issue size of Aakaar Medical Technologies IPO is up to ₹25.64 Cr whereas the issue size of the Turtle Infratrade IPO is up to ₹10.80 Cr. The final issue price of Aakaar Medical Technologies IPO is ₹72.00 per share and of Turtle Infratrade IPO is ₹40.00 per share.

 Aakaar Medical Technologies IPOTurtle Infratrade IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹68.00 per share
Issue Price (Upper)₹72.00 per share
Issue Price (Final)₹72.00 per share₹40.00 per share
Discount (Retail)₹0.00 per share
Discount (Employee)₹0.00 per share
Market Lot Size1600 shares3000 shares
Fresh Issue Size35,61,600 shares27,00,000 shares
Fresh Issue Size (Amount)up to ₹25.64 Crup to ₹10.80 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total35,61,600 shares27,00,000 shares
Issue Size Total (Amount)up to ₹25.64 Crup to ₹10.80 Cr

IPO Timetable

Aakaar Medical Technologies IPO opens on Jun 20, 2025, while Turtle Infratrade IPO opens on . The closing date of Aakaar Medical Technologies IPO and Turtle Infratrade IPO is Jun 24, 2025, and , respectively.

Financials & KPIs

Aakaar Medical Technologies IPO P/E ratio is 12.43, as compared to Turtle Infratrade IPO P/E ratio of 5.4.

 Aakaar Medical Technologies IPOTurtle Infratrade IPO
Financials

Company Financials (Restated)

Aakaar Medical Technologies Ltd.'s revenue increased by 33% and profit after tax (PAT) rose by 110% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets51.8534.0123.23
Total Income61.7646.2732.88
Profit After Tax6.042.872.15
EBITDA9.745.003.53
NET Worth23.2012.539.66
Reserves and Surplus12.7811.848.96
Total Borrowing22.7415.065.87
Amount in ₹ Crore

Company Financials (Restated Consolidated)

Period Ended30 Sep 202431 Mar 202431 Mar 202331 Mar 2022
Assets29.3933.3847.9434.60
Total Income50.58178.64125.38246.21
Profit After Tax0.695.571.322.97
NET Worth13.3912.697.166.19
Reserves and Surplus5.8712.376.835.86
Total Borrowing3.307.3710.1213.92
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)91.11100
Promoter Shareholding (Post-Issue)67.0173.58
P/E Ratio12.435.4
Market Cap₹102.04 Cr.₹40.88 Cr.
ROE43.89%
ROCE21.02%27.77%
Debt/Equity0.98
EPS₹5.79₹7.41
RoNW33.81%43.89%

Shares Offered

In the Aakaar Medical Technologies IPO Retail Individual Investors (RII) are offered 12,48,000 shares while in Turtle Infratrade IPO retail investors are offered 12,48,000 shares. Qualified Institutional Buyers (QIB) are offered 7,12,000 shares in Aakaar Medical Technologies IPO and in Turtle Infratrade IPO.

 Aakaar Medical Technologies IPOTurtle Infratrade IPO
Anchor Investor Reservation10,67,200 shares
Market Maker Reservation1,88,800 shares1,38,000 shares
QIB7,12,000 shares
NII5,34,400 shares
RII12,48,000 shares
Employee0 shares
Others
Total35,61,600 shares

Bids Received (Subscription)

Aakaar Medical Technologies IPO subscribed 2.28x in total, whereas Turtle Infratrade IPO subscribed .

Compare with others

Compare:

Aakaar Medical Technologies IPO Vs Turtle Infratrade IPO